The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gadzhigoroeva A.G.

I.M. Sechenov Moscow Medical Academy

Kogan E.A.

Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova, Moskva

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Tereshchenko G.P.

I.M. Sechenov Moscow Medical Academy

Demura T.A.

Kafedra patologicheskoĭ anatomii im. I.M. Strukova Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova

Relative significance of apoptotic and proliferative processes, neoangiogenesis, and cellular differentiation for immune inflammation at sites affected by circumscribed alopecia

Authors:

Gadzhigoroeva A.G., Kogan E.A., Potekaev N.N., Tereshchenko G.P., Demura T.A.

More about the authors

Read: 1819 times


To cite this article:

Gadzhigoroeva AG, Kogan EA, Potekaev NN, Tereshchenko GP, Demura TA. Relative significance of apoptotic and proliferative processes, neoangiogenesis, and cellular differentiation for immune inflammation at sites affected by circumscribed alopecia. Russian Journal of Clinical Dermatology and Venereology. 2010;8(2):25‑34. (In Russ.)

References:

  1. Messenger A.G., Bleehen S.S. Expression of HLA-DR by anagen hair follicles in alopecia areata. J Invest Dermatol 1985; 85: 6: 569-572.
  2. McElwee K.J., Tobin D.J., Bystrin J.C. et al. Alopecia areata: an autoimmune disease. Exp Dermatol 1999; 8: 371-379.
  3. Price V.H. Alopecia areata is a T-cell mediated autoimmune disease in with anagen hair bulbs are targeted by CD8+ and CD4+ lymphocytes. JEADV 2004; 18: 2: 69-71.
  4. Happle R., Hausen B.M., Wiesner-Menzel L. Dyphencyprone in the treatment of alopecia areata. Acta Derm Venereol (Stockh) 1983; 63: 49-52.
  5. Perret C., Wiesner-Menzel L., Happle R. Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrares of alopecia areata. Acta Derm Venereol (Stockh) 1984; 64: 26-30.
  6. Ranki A., Kianto U., Kanerva L. et al. Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia areata, totalis and universalis. J Invest Dematol 1984; 83: 7-11.
  7. Happle R., Perret C., Wiesner-Menzel L. Treatment of alopecia areata with diphencyprone induces hair regrowth and affects the composition of peribulbar infiltrates. In: MacDonald D.M. (ed). Immunodermatology. London: Butterworth 1984: 279-86.
  8. Tosti A. Dermoscopy of hair and scalp disorders with clinical and patho­logical correlations. Informa UK. 2007.
  9. Gadzhigoroeva A.G. Primenenie dermoskopii pri gnezdnoi alopetsii. Zh. Eksper i klin dermatokosmetol 2009; 2: 58-60.
  10. Kogan E.A., Ignatova V.E., Unanyan A.L., Sidorova I.S. Sostoyanie protsessov proliferatsii i apoptoza v raznykh gistologicheskikh tipakh leiomiomy matki. Arkh patol 2005; 4: 32-37.
  11. Duvic M., Welsh E.A., Jackow C. et al. Analysis of HLA-D locus alleles in alopecia areata patients and families. J Invest Dermatol 1995; 104 (5 Suppl): 5S-6S.
  12. Colombe B.W., Lou C.D., Price V.H. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J Investig Dermatol Symp Proc 1999; 4: 3: 216-219.
  13. Gadzhigoroeva A.G. Topicheskaya immunosupressivnaya terapiya gnezdnoi alopetsii v kompleksnykh metodikakh s dalarginom i elektropunkturoi: Dis … kand. med. nauk. M 1999.
  14. Kalish R., Johnson K., Hordinsky M. Alopecia Areata. Autoreactive T Cells are variably enriched in scalp lesions relative to peripheral blood. Arch Dermatol 1992; 128: 1072-1077.
  15. Gilhar A., Ullmann Y., Berkutzki T. et al. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 1998; 101: 2-67.
  16. Nickoloff B.J., Griffiths C.E.M. Aberrant intercellular adhesion molecule-1 (ICAM-1) expression by hair-follicle epithelial cells and endothelial leukocyte adhesion molecule-1(ELAM-1) by vascular cells are important adhesion-molecule alterations in alopecia areata. J Invest Dermatol 1991; 96 (Suppl): 91S-92S.
  17. Gupta A., Ellis C., Cooper K. et al. Oral cyclosporin for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol 1990; 22: 242.
  18. McDonagh A.J.G., Snowden J.A., Stierle C. et al. HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: the role of cytokines. Br J Dermatol 1993; 129: 250-256.
  19. Sarkisov D.S. Strukturnye osnovy adaptatsii i kompensatsii narushennykh funktsii. M: Meditsina 1987.
  20. Botchkarev V.A., Botchkareva N.V., Welker P. et al. New roles for neurotrophins: involvement of brain-derived neurotrophic factor and neurotrophin-4 in hair cycle control. FASEB J 1999; 13: 395-410.
  21. Botchkarev V.A., Komarova E.A. et al. p53 Involvement in the control of murine hair follicle regression. Am J Pathol 2001; 158: 6: 1913-1919.
  22. Tobin C.J., Fenton D.A., Kendall M.D. Cell degeneration in alopecia areata. Am J Dermatopathol 1991; 13: 248-256.
  23. Norris D.A., Duke R., Whang K., Middleton M. Immunologic cytotoxyci in alopecia areata: apoptosis of dermal papilla cells in alopecia areata. J Invest Dermatol 1995; 104 (Suppl): 8S-9S.
  24. Sayama K., Yonehara S., Watanabe Y., Miki Y. Expression of Fas-antigen on keratinocyte cultures in vivo and induction of apoptosis in cultured keratinocytes. J Invest Dermatol 1994; 103: 330-334.
  25. Linder G., Botchkarev V.A., Botchkareva N.V. et al. Analysis of apoptosis during hair follicle regression (catagen). Am J Pathol 1997; 151: 1601-1617.
  26. Happle R., Hoffmann R. Cytokine patterns in alopecia areata before and after topical immunotherapy. J Invest Dermatol 1995; 104: 5: 14S-15S.
  27. Hoffmann R., Wenzel E., Huth A. et al. Growth factor mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. Acta Dermatol Venereol 1996; 76: 17-20.
  28. Sato-Kawamura M., Aiba S., Tagami H. Strong expression of CD40, CD54, and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Arch Dermatol Res 2003; 294: 536-543.
  29. Cotsarelis G. et al. Label-retaining cells resident in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990; 61: 1329-1337.
  30. Ohyama M. Advances in the Study of Stem-Cell-Enriched Hair Follicle Bulge Cells: A Review Featuring Characterization and Isolation of Human Bulge Cells. Dermatology 2007; 214: 342-351.
  31. Liu Y., Cotsarelis G. et al. Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge. J Invest Dermatol 2003; 121: 963-968.
  32. Stenn K.S., Lawrence L., Veis D. et al. Expression of the bcl-2 protooncogene in the cycling adult mouse hair follicle. J Invest Dermatol 1994; 103: 107-111.
  33. Rabson A., Roit A., Delvz P. Osnovy meditsinskoi immunologii. Per. s angl. M: Mir 2006.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.